Annual report pursuant to Section 13 and 15(d)

INVESTMENTS IN ASSOCIATE, NET (Tables)

v3.10.0.1
INVESTMENTS IN ASSOCIATE, NET (Tables)
12 Months Ended
Nov. 30, 2018
Schedule of Investments [Table Text Block]
    November 30,  
    2018     2017  
    (In thousands)  
             
Opening balance $ 1,321   $ (12 )
Reclass with short-term receivables   (795 )   118  
Investments during the period   -     2,429  
Share in losses   (731 )   (1,214 )
Reductions due to the acquisition of CureCell and Atvio – see also Note 4   205     -  
  $   -   $ 1,321